Blog

A devoted father searching around the world for help finds the care his son needs at Pacific Neuroscience Institute. Read Basab’s story below. A Search for Medical Help and Hope One can only imagine the anguish of Deg Gharti Chhetri by the fall of 2018....

Find out more about how an international patient's trip to PNI saved both her life, and the life of her unborn child.

Dr. Daniel Kelly Presents Strategies for Maximizing Tumor Removal and Gland Preservation for Pituitary Adenomas and Rathke's Cleft Cysts. Find out more.

Actor Jay Huguley recounts how sudden loss of eyesight and color perception in his left eye led to his surprising brush with minimally invasive brain surgery. Find out more in his video testimonial for Pacific Neuroscience Institute.

Pacific Neuroscience Institute is very pleased to announce an expansion of its clinical space associated with Providence Little Company of Mary Medical Center Torrance. The new state-of-the-art clinics for brain, pituitary, movement and spine conditions are located at 5215 Torrance Blvd., Suite 300. Find out more.

Keyhole surgery is the concept of safely removing brain, skull base and pituitary tumors through smaller, more precise openings that minimize collateral damage to surrounding scalp, brain, blood vessels and nerves. A majority of these tumors can now be removed via one of the several keyhole approaches available nowadays, using a small craniotomy (bony skull opening) or an approach through the nostrils. These approaches are technically demanding, require specialized instrumentation, significant surgical expertise and are not appropriate for all tumors. Find out more.

What is it like to be a brain surgeon? Take a look behind the scenes and follow a young doctor through his day as a neurosurgery fellow in a busy practice at Pacific Neuroscience Institute in Santa Monica, California.

Electrical stimulation therapy may have a big impact on brain health and recovery in patients with mood disorders, dementia and neurodegenerative disorders.

Pacific Neuroscience Institute, the leading enrollment site for the MDNA55 clinical trial for Glioblastoma, is still open and enrolling eligible patients. This innovative phase 2 study is for the minimally invasive convection-enhanced delivery (CED) of a new bioengineered targeted therapeutic, MDNA55, in adults with recurrent or progressive glioblastoma. Read more.

The development of 3D printing, 3D imaging, and HD imaging, has brought the highest quality in imaging modalities to the field of neurosurgery. 3D renders and models can be used in diagnosis and planning stages of treatment and care for conditions such as brain tumors, skull base or pituitary tumors, and facial pain syndromes. Learn more.